EN DE
  • Paion GmbH
  • Company

    About PAION

    1. History
    2. Management
  • Insolvency Proceedings
  • Media and Investors

    At a glance

    1. General Information

    Newsroom

    1. Press Releases
    2. Ad-hoc Releases
    3. Directors' Dealings
    4. Holdings in company

    Information on shares

    1. Chart & Fact sheet
    2. Analysts
    3. Capital actions
    4. Information on CeNeS Acquisition

    Investorcenter

    1. Financial Reports
    2. Presentations
    3. Corporate calendar

    Corporate Governance

    1. Declaration on Corporate Governance
    2. Articles of Association
    3. Declaration of Conformity
    4. Code of Conduct
    5. By-Laws Supervisory Board
    6. Compensation Management Board and Supervisory Board

    Annual general meeting

    2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
  • Contact

    Germany

    UK

    Netherlands

Here you will find information on PAION AG i.L. relevant to stock corporation and stock exchange law.

The operating business of PAION AG i.L. and PAION Deutschland GmbH i.L. has been transferred to PAION Pharma GmbH as part of the insolvency proceedings.

You can reach PAION Pharma GmbH at www.paionpharma.com

  • Media and Investors
  •  »  Newsroom
  •  »  Press Releases
  •  »  2014
  • 11/05/2014

    Nine month results 2014: Earnings call and webcast (in English) on 05 November 2014

    • PDF

    • MP3

  • 11/05/2014

    PAION AG reports results for the first nine month 2014

    • PDF

  • 10/27/2014

    PAION founds USA based subsidiary and engages an experienced U.S. industry expert as CEO

    • PDF

  • 10/14/2014

    Conference Call about the project status of Remimazolam in Japan

    • PDF

    • MP3

  • 10/14/2014

    Invitation to conference call of PAION about the project status of Remimazolam

    • PDF

  • 10/01/2014

    Two scientific Remimazolam presentations are accepted for ASA and ACG meeting in October 2014

    • PDF

  • 09/24/2014

    PAION AG grants license to YichangHumanwell for M6G in China

    • PDF

  • 08/27/2014

    Abdelghani Omari appointed as new Chief Financial Officer at PAION AG

    • PDF

  • 08/06/2014

    Half year results 2014: Earnings call and webcast (in English) on 06 August 2014

    Playback No: +49 69 20 17 44 221

    Reference No: 352995#

    • PDF

    • MP3

  • 08/06/2014

    PAION AG reports financial results for the first half year 2014

    • PDF

  • 07/09/2014

    PAION grants licence to Remimazolam in Canada to Pendopharm

    • PDF

  • 06/18/2014

    PAION AG starts capital increase with subscription rights through the issue of 18.5 million shares at EUR 2.50 per share

    • PDF

  • 06/17/2014

    PAION grants licence for “Mena Region" to R-Pharm

    • PDF

  • 06/13/2014

    PAION grants Pendopharm exclusive option to Remimazolam in Canada

    • PDF

  • 05/28/2014

    PAION reports positive Phase II results of its short acting anaesthetic Remimazolam in major cardiac surgery

    • PDF

  • 05/21/2014

    Annual general Meeting approved share capital increase and elected

    • PDF

  • 05/07/2014

    PAION AG reports results for the first quarter 2014

    • PDF

  • 04/11/2014

    PAION AG plans capital increase with subscription rights by issuing up to 18.5 million shares to fund the Remimazolam programmes required for approval in the US and EU

    • PDF

  • 04/07/2014

    Planned transition in Prime Standard completed

    • PDF

  • 03/12/2014

    PAION AG reports financial results for the full year 2013

    • PDF

  • 02/11/2014

    PAION completes Phase II study with Remimazolam in indication anaesthesia

    • PDF

  • 01/16/2014

    PAION AG plans to issue up to 2.5 million shares in a private placement

    • PDF

  • 01/15/2014

    PAION AG successfully completes capital increase with subscription rights

    • PDF

  • copyright © PAION AG I all rights reserved
  • Imprint
  • Privacy Statement
  • General Terms and Conditions
Paion

Heussstraße 25 | 52078 Aachen | Deutschland

Tel.: +49 241 4453-0 | Fax.: +49 241 4453-100 | e-mail: info@paion.com

Company
  1. About PAION +
    1. History
    2. Management
Insolvency Proceedings
Media and Investors
  1. At a glance +
    1. General Information
  2. Newsroom +
    1. Press Releases
    2. Ad-hoc Releases
    3. Directors' Dealings
    4. Holdings in company
  3. Information on shares +
    1. Chart & Fact sheet
    2. Analysts
    3. Capital actions
    4. Information on CeNeS Acquisition
  4. Investorcenter +
    1. Financial Reports
    2. Presentations
    3. Corporate calendar
  5. Corporate Governance +
    1. Declaration on Corporate Governance
    2. Articles of Association
    3. Declaration of Conformity
    4. Code of Conduct
    5. By-Laws Supervisory Board
    6. Compensation Management Board and Supervisory Board
  6. Annual general meeting +
    1. 2023
    2. 2022
    3. 2021
    4. 2020
    5. 2019
    6. 2018
    7. 2017
    8. 2016
    9. 2015
    10. 2014
    11. 2013
    12. 2012
    13. 2011
Contact
  1. Germany
  2. UK
  3. Netherlands
Cookie Settings

This website uses cookies.

Some of them are essential and required for running the website. Others improve your user experience and may be activated or deactivated at your discretion.

Accept all Save
Privacy Statement Imprint